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Abstract
Background: The therapeutic use of multipotent stem cells depends on their differentiation potential, which has been
shown to be variable for different populations. These differences are likely to be the result of key changes in their epigenetic
profiles.
Methodology/Principal Findings: to address this issue, we have investigated the levels of epigenetic regulation in well
characterized populations of pluripotent embryonic stem cells (ESC) and multipotent adult stem cells (ASC) at the
trancriptome, methylome, histone modification and microRNA levels. Differences in gene expression profiles allowed
classification of stem cells into three separate populations including ESC, multipotent adult progenitor cells (MAPC) and
mesenchymal stromal cells (MSC). The analysis of the PcG repressive marks, histone modifications and gene promoter
methylation of differentiation and pluripotency genes demonstrated that stem cell populations with a wider differentiation
potential (ESC and MAPC) showed stronger representation of epigenetic repressive marks in differentiation genes and that
this epigenetic signature was progressively lost with restriction of stem cell potential. Our analysis of microRNA established
specific microRNA signatures suggesting specific microRNAs involved in regulation of pluripotent and differentiation genes.
Conclusions/Significance: Our study leads us to propose a model where the level of epigenetic regulation, as a
combination of DNA methylation and histone modification marks, at differentiation genes defines degrees of differentiation
potential from progenitor and multipotent stem cells to pluripotent stem cells.
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Introduction
The progressive restriction of the differentiation potential from
pluripotent embryonic stem cells (ESC) to different populations of
multipotent adult stem cells (ASC) depends on the orchestrated
action of key transcription factors and changes in the profile of
epigenetic modifications that ultimately lead to expression of
different sets of genes. ESC are unique in their capacities to self-
renew and differentiate into any somatic and germ line tissue [1,2],
while, by contrast, the differentiation potential of ASC is limited.
ESC are characterized by an unusual chromatin features where
marks of open chromatin, such as acetylated H3K9 and
trimethylated H3K4, are combined with repressive histone
modifications like H3K27 trimethylation at some non-expressed
genes [3,4,5,6,7]. Specifically, various studies indicate that a
number of key developmental and pluripotency genes are marked
by bivalent marks of chromatin activation (H3K4me3) and
repression (H3K27me3) that maintain genes in a ‘‘transcription-
ready’’ state that allows rapid transcription activation upon
differentiation of ESC [4,5]. This bivalent domain signature is also
present in differentiated cell types [7,8,9] suggesting that the
number of promoters with bivalent modifications gradually
decreases as the ESC differentiate thus corresponding to the degree
of potency of a certain population of cells [9]. A key component
implicated in the establishment of this epigenetic signature in the
regulation of ESC is the Polycomb group family of proteins, which
are responsible for maintaining the pluripotent state by epigenetic
repression of developmental genes through the presence of
repressive chromatin marks in the promoter regions of genes [10].
Promoter methylation is a second mechanism regulating
pluripotency, commitment, and phenotypic maturation and
differentiation of ESC. Previous studies indicating that methyla-
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tion of key regulatory genes may play an important role in
differentiation of ESC [11,12] have been built upon by more
recent ones that have used high-throughput strategies for DNA
methylation profiling. The latter have demonstrated that gene
regulation mediated by promoter CpG methylation in ESC
complements other transcriptional mechanisms such as those
mediated by OCT4 or NANOG, which are responsible for
appropriate gene expression [13]. Mohn et al have proposed a
model in which stem cell differentiation is associated with
methylation of gene promoters (pluripotency genes) in lineage-
committed progenitor cells while changes in histone marks are also
acquired [14]. This suggests de novo DNA methylation is a dynamic
switch that participates in the restriction of the developmental
potential of progenitor cells.
Recent studies have provided strong evidence that microRNAs
(miRNAs) also play critical roles in the differentiation potential of
stem cells [15], which represents a third mechanism of stem cell
regulation. miRNA expression profiles in human and mouse ESC
reveal that they express a unique set of miRNAs that become
downregulated when these cells differentiate, suggesting a role for
miRNAs in the maintenance of pluripotency [16]. Moreover,
regulation of pluripotency genes such as NANOG, OCT4 and SOX2
is mediated by specific miRNAs that have the ability to induce
transcriptional silencing of these genes, resulting in differentiation
of ESC [17,18]. miRNAs are also important for ESC differenti-
ation [19]. Knockout of Dicer, an RNase III-family nuclease
required for miRNA maturation, compromises ESC proliferation
and differentiation [20] while expression of certain miRNAs plays
a critical role in ectodermal [21], cardiac [22] and muscle [23]
lineage differentiation. The recently completed comprehensive
profiling of miRNA expression in different tissues [24] will be of
great use in determining whether employing the correct
combination of miRNAs may facilitate the generation of
homogeneous cell populations of desired lineages from ESC.
The comparison of gene expression profiles has given us a better
understanding of the differences between populations of stem cells
[25,26,27]. Although populations of stem cells with the ability to
self-renew and differentiate have been isolated from most adult
tissues, mesenchymal stromal cells isolated from bone marrow
(MSC) and adipose tissue (ADSC) are the most thoroughly
investigated populations of stem cells in the clinical setting. Uses
for MSC are being explored in relation to the treatment of cardiac
and vascular diseases, orthopedic diseases and, even more recently,
in immune-mediated diseases such as diabetes and Crohn’s disease
[28]. In contrast to ESC, the potential of MSC is restricted to
mesodermal cell types such as adipocytes, osteocytes, chondrocytes
and, in some instances, skeletal muscle cells [29]. A population of
ASC closely related to MSC, known as multipotent adult
progenitor cells (MAPC), has recently been isolated from the
bone marrow of humans and animals. MAPC have a greater
potential to differentiate not only into the classical mesoderm-
derived tissues but also into other tissues, such as endothelium and
hepatocytes [30,31,32]. Recent studies have shown that the
differences in the gene expression profile between murine ESC,
MSC and MAPC reflect the stem cell differentiation potential and
may form the basis of studies designed to provide insights into
genes that confer the greatest developmental potency [33].
The role of epigenetic mechanisms in regulating differentiation
and self-renewal of adult stem cells has been less extensively
addressed. It is likely that a comparison between the epigenetic
profiles of somatic stem cells and ESC will provide novel insights
into the mechanisms involved in reprogramming of somatic cells
and clues to understanding why certain somatic stem cells, such as
neural stem cells, require fewer factors than others, such as
fibroblasts [34]. In the current study, we have performed a high-
throughput comparison at the gene expression, histone modifica-
tion, DNA methylation and miRNA expression level of well
characterized and defined populations of human stem cells, from
pluripotent ESC to more restricted stromal cells derived from bone
marrow and adipose tissue. Our results provide a direct
connection between changes in the epigenetic signature and
progression from pluripotency of ESC cells to restriction of the
differentiation potential in MSC and ADSC, highlighting the
existence of intermediate states of potency that exhibit specific
epigenetic profiles.
Results
Isolation and Characterization of Stem Cell Populations
We first compared the differentiation potential of three different
stem cell populations: mesenchymal stromal cells (MSC) isolated
from human bone marrow, adipose tissue-derived stem cells
(ADSC) and human multipotent adult progenitor cells (MAPC).
MSC and ADSC populations met the criteria established by the
International Society for Cellular Therapy (ISCT) for defining
mesenchymal stromal cells [35]. MSC grew as adherent cells with
fibroblastic morphology, were positive for HLA-ABC, CD73,
CD105, CD29, CD13, CD44, CD90 and CD140b surface
markers, and negative for CD34 and CD45 (not shown). MAPC
were isolated from the same patients from whom MSC were
obtained, and grown as previously described [30,36]. Human
MAPC expressed low levels of the CD44 antigen, were negative
for HLA class I2, CD342, CD452, MHC-II2 and CD362, and
expressed CD90+ and CD13+ (not shown).
MSC and ADSC were able to differentiate to adipogenic,
osteogenic and chondrogenic lineages using specific culture
medium. Differentiation was not observed in human fibroblasts
under the same conditions. In vitro, MAPC demonstrated a
differentiation potential to endothelial cells, smooth muscle cells,
as well as bone, cartilage and adipocytic cells, indicating a greater
potential than MSC and ADSC (not shown).
Transcriptome Analysis of Stem Cells
Gene expression was then analyzed using the Affymetrix HG-
U133 Plus 2.0 GeneChip Oligonucleotide Microarray. We
compared the expression profile of the above stem cell populations
with NTERA-2 cells, a human embryonic carcinoma stem-cell
line. Previous gene expression profile studies have demonstrated
that NTERA-2 cells cluster together with human ESC supporting
their use as a model of ESC [37]. Hierarchical cluster analysis
generated using all the probe sets included in the array classified
the different independent cell populations NTERA-2 (n= 3),
MAPC (n= 10), MSC (n= 8) and ADSC (n= 5) into three discrete
clusters that include NTERA-2, MAPC and a third cluster
including ADSC and MSC (Figure 1A and Table S2). We also
used PCA to explore further the cell-type relationships of the
various stem cell populations. PCA clearly separated the MAPC,
MSC, ADSC and NTERA-2 populations into four groups.
Moreover, it showed that 53% of the total variance in the data
was explained by the differences between the NTERA-2 cell line
and the rest of the populations, 36% of the variance was due to
differences between MAPC and MSC-ADSC populations, and
only 6% of the variance was due to differences between MSC and
ADSC populations (Figure S1).
Two additional sets of comparisons were then made. First, we
compared the transcriptome of NTERA-2 with all other ASC to
determine the differences between pluripotent (NTERA-2) and
multipotent stem cells. Second, we also compared the different
Epigenetics of Stem Cells
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Figure 1. Hierarchical clustering and supervised analysis of consensus ESC genes and differentiation genes. Dendrogram of hierarchical
cluster analysis based on the expression of all genes (A), of the consensus ESC genes (B) and consensus differentiation genes (D) included in the HG-
U133 Plus 2.0 chip. Hierarchical clustering (Euclidian distance) was performed with the TIGR MeV v. 2.2 program. Analysis of the differential expression
of consensus ESC genes (C) and consensus differentiation genes (E) between the populations of stem cells using the significant analysis of microarrays
(SAM) algorithm. Values are shown as the percentage of genes that belong to the consensus ESC or consensus differentiation gene lists that are
differentially expressed in each group after comparison with SAM. The number of deregulated genes is indicated in parentheses. Only deregulated
genes with FC.2 were considered.
doi:10.1371/journal.pone.0007809.g001
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populations of ASC (MAPC versus MSC and ADSC) to determine
expression profiles that might explain the differences observed
between ASC, which were the second largest cause of variability in
the data, as clearly indicated by the PCA. These analyses were
performed with LIMMA to identify differentially expressed probe
sets (see Supplementary Materials and Methods). The functional
classification, using gene ontology (GO) annotation, of the
differentially expressed probe sets in the first comparison
(NTERA-2 versus ASC) showed that NTERA-2 cell line was
enriched in genes involved in DNA modification, repair,
replication, DNA packaging, chromatin modification, mitosis
and transcription. The latter included transcription factors that
are enriched in ESC, such as SOX2, NANOG, OCT3/4 (POU5F1),
SALL3 or ZIC3. In contrast, some of the categories over-
represented in ASC were involved in developmental processes
(skeletal and blood vessel development), cell differentiation, cell
adhesion, organ morphogenesis, wound healing, angiogenesis, NF-
kappaB signaling and collagen fibril organization (Figure S2 and
Table S3). The comparison of the populations of ASC yielded an
enrichment in MAPC for genes involved in mitosis and DNA
repair while categories represented in MSC and ADSC were
related to development (including muscle and skeletal develop-
ment), cell and cell-matrix adhesion and signaling (TGF-beta and
JAK-STAT signaling) (Figure S2 and Table S4). The results of
both comparisons suggest that MAPC represent a population with
intermediate characteristics between ESC and other populations
of adult stem cells such as MSC and ADSC.
A recent meta-analysis of the results of 38 studies compared the
transcriptome of human ESC with differentiated cells identifying a
gene list that included transcripts that are over-expressed in ESC
(consensus ESC gene list, n = 1.076), and a second list that included
genes underexpressed in ESC (consensus differentiation gene list,
n = 783) [38]. We determined the gene expression for both
consensus gene lists in our cell populations using hierarchical
clustering and the SAM algorithm. The hierarchical clustering of
the consensus ESC genes in the Affymetrix array (n = 915) revealed
that NTERA-2 cells grouped separately from MAPC, MSC and
ADSC (Figure 1B). SAM analysis showed that NTERA-2 samples
expressed more consensus ESC genes than each group of ASC
(Figure 1C) (Table S5). Interestingly, when the same comparison
was made of the consensus differentiation genes present in the
Affymetrix array (n = 669), MAPC and NTERA-2 cells grouped
together, separately from MSC and ADSC (Figure 1D). In
addition, SAM analysis revealed the expression of a higher
percentage of consensus differentiation genes in MSC and ADSC than
in NTERA-2 cells and MAPC (Figure 1E) (Table S6A and S6B).
These results were confirmed by real-time PCR (Q-RT-PCR)
using some of the consensus ESC genes (SOX2, NANOG, ZIC3) and
consensus differentiation genes involved in muscle development
(GATA6, IGFBP3), skeletal development (FBN1, CDH11) and
extracellular matrix (EFEMP1, LUM, MMP2). We also included
two randomly selected genes (SDF1, EPAS1) from the LIMMA
analysis (Figure 2). These results might explain the greater
potential of MAPC compared with other populations of ASC
such as MSC and ADSC [30,31] and allow MAPC and
pluripotent ESC to be distinguished.
Stem Cell Regulation by Polycomb Proteins and Histone
Modifications
Recent studies have demonstrated that Polycomb group (PcG)
proteins participate in the repression of developmental genes that
are activated during ESC differentiation [10,39,40]. For instance,
mapping the sites occupied by SUZ12, one of the subunits of the
Polycomb repressive complex 2 (PRC2), throughout the genome in
human ESC, indicated that SUZ12 occupies the promoter regions
of a large group of developmental regulators [10]. To test the role of
PcG-mediated epigenetic regulation of the different expression
signatures in NTERA-2 cells and ASC we used bioinformatic tools
to examine whether consensus ESC and differentiation genes from our
expression analysis were marked by PcG. Of all the consensus ESC
genes described in the meta-analysis of Assou et al. [38] (n= 1,076),
only 5% showed a PRC2 mark (EED, SUZ12 or H3K27me3). A
similar percentage of these marks was observed in the consensus ESC
genes in our study that were upregulated in NTERA-2 with respect to
ASC (n= 554, detected by SAM analysis) (Figure 3A) (Table S5).
However, we found a higher percentage (17.5%) of genes in the
consensus differentiation genes that were marked by PcG proteins. This
percentage was even higher when we considered differentiation genes
that were upregulated in ASC relative to NTERA-2 cells and in
MSC-ADSC versus MAPC in our study (Figure 3B) (Table S6A-B).
These results suggest that PcG-mediated regulation of gene
expression in stem cells may be more important for genes among
the consensus differentiation gene than for genes that belong to the
consensus ESC genes.
To demonstrate that PRC2 is indeed involved in the regulation
of differentiation genes, we performed quantitative-ChIP assays
using antibodies against EZH2, SUZ12 and H3K27m3 (marks
associated with repressed chromatin), and two histone modifica-
tions associated with transcriptionally active chromatin, trimethy-
lated histone H3 at lysine 4 (H3K4me3) and acetylated histone H3
(H3Ac), in the various stem cell populations. The promoters of
some of the differentiation genes that were previously validated by
Q-RT-PCR (Figure 2) and were associated with PcG marks
according to the results of Lee et al [10] were used for the analysis.
We observed that, consistent with the expression analysis,
differentiation gene promoters in ASC showed a decrease in repressed
chromatin marks (mostly SUZ12 and, to a lesser degree, EZH2
and H3K27me3) relative to NTERA-2. This decrease was also
found in MSC and ADSC when they were compared with MAPC
(Figure 3C). On the other hand, an increased presence of active
marks (H3K4me3 and/or H3Ac) on the promoters of these genes
was observed in ASC in comparison with NTERA-2 (Figure 3C).
Some of the genes, such asMMP2, EPAS1 and GATA6, exhibited a
higher level of occupancy of SUZ12, EZH2 and H3K27me3 in
MAPC than in MSC and ADSC, which suggests PcG-dependent
regulation in MAPC. The reduction in repressed marks, together
with the increase of active marks in ASC, suggests a favorable
balance for the expression of differentiation genes in these cells,
while the differences observed between MSC-ADSC and MAPC
suggest that epigenetic mechanisms are probably involved in
determining the different potential of these populations of adult
stem cell.
Promoter DNA Methylation in Stem Cells
Since promoter CpG methylation has also been demonstrated
to contribute to the regulation of gene expression in ESC [13], we
analyzed the DNA methylation profiles of the different populations
of stem cells (MSC, ADSC, MAPC and NTERA-2 cells) using the
BeadArray technology [41,42]. The array contains 807 gene
promoters, including 7.4% (n= 80) and 14.4% (n= 113) of the
genes in the consensus ESC and differentiation list described by Assou
et al, respectively. [38] (Table S7, S8A–S8B). Hierarchical
clustering produced two discrete groups, one containing
NTERA-2 samples and the other group comprised of all ASC
populations (not shown).
We next compared the DNA methylation status of NTERA-2
and the various ASC populations. Of a total of 83 genes that were
differentially methylated between NTERA-2 cells and ASC (Table
Epigenetics of Stem Cells
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S9), 99% (n= 82) were hypomethylated in ASC and hypermethy-
lated in NTERA-2 cells (Figure S3). Fourteen of these genes had
PcG marks (17%) and eight belonged to the consensus differentiation
genes (10%), two of them with PcG marks. In contrast, none of the
differentially methylated genes belonged to the group of the
consensus ESC genes. According to gene ontology, hypomethylated
genes in ASC were involved in signal transduction, cell-cycle
arrest, induction of apoptosis and development. The hypermethy-
lation of these genes could serve as a molecular lock to ensure
proliferation in pluripotent stem cells, while prevents their
differentiation. The number of genes differentially methylated
between ASC populations was limited to less than 4% of the gene
promoters in the array (Table S9 and Figure S3). Interestingly, 27
genes (3.3% of those analyzed) were differentially methylated
between ADSC and MSC (Table S9 and Figure S3). While MSC
had 24 hypermethylated genes, ADSC featured only three
methylated genes. On the other hand, only seven and three genes
were differentially methylated between MAPC versus MSC and
MAPC versus ADSC, respectively.
To establish whether promoter methylation participated in the
regulation of genes differentially expressed in NTERA-2 cells and
ASC we analyzed the gene expression using transcriptome data
and the SAM algorithm and found that 56% of the hypomethy-
lated genes in ASC (n= 46) were overexpressed in these cells in
comparison with NTERA-2, (Table S10 and Figure 4A). Among
the most differentially expressed genes were COL1A2, COL1A1,
SERPINE1, DLC1, DDR2 and PDGFRB, which were also listed as
differentiation genes. These results were validated by bisulfite
sequencing and Q-RT-PCR for three of the differentially
methylated and expressed genes (COL1A2, HOXA9 and SER-
PINE1) (Figure 4B–C). On the other hand, eight of the 27 genes
differentially methylated in MSC and ADSC showed differences in
expression that were greater than two (FC.2) in only two cases.
Finally, the comparison between genes regulated by PcG [10] and
regulated by promoter methylation indicates that these two
mechanisms overlapped to a degree in the regulation of specific
gene expression. Taken together, these results suggest that gene
promoter methylation plays a more significant role in silencing
differentiation and developmental genes in pluripotent stem cells
(NTERA-2) than in regulating ESC genes in adult stem cells.
MicroRNA Expression Profile in Stem Cells
We finally examined the expression of 250 mature human
miRNAs listed in the Sanger database (version 9.0 [October
Figure 2. Expression of genes from the consensus ESC and differentiation genes lists in NTERA-2, MAPC, MSC and ADSC cells by Q-RT-
PCR. Gene expression was measured using the relative standard curve method. GAPDH was used as a housekeeping control. Expression values of
each sample from Affymetrix arrays (logarithmic scale: rhombuses) and from Q-RT-PCR analysis (percentages: bars) are shown for each gene. Q-RT-
PCR results are expressed on the secondary vertical axis as a % of expression relative to NTERA-2 for consensus ESC genes, and to MSC for consensus
differentiation genes. Each bar represents the value of a different cell line.
doi:10.1371/journal.pone.0007809.g002
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Figure 3. Consensus ESC and differentiation genes with predicted Polycomb group marks, and regulation of differentiation genes by PcG
proteins in stem cells. A, Bar graph displaying the percentage of genes targeted by PcGmarks among the consensus ESC gene list and among the ESC
genes upregulated in NTERA-2 cells relative to ASC. B, Bar graph displaying the percentage of genes targeted by PcG marks among the consensus
differentiation gene list, the differentiation genes upregulated in ASC relative to NTERA-2 cells, and differentiation genes upregulated in MSC and ADSC
versus MAPC. The numbers in brackets represent the total number of genes. C, Occupancy of EZH2, SUZ12, H3K27m3, H3K4me3 and H3 acetylated,
assessed by Q-ChIP-PCR, in the promoters of differentiation genes. Enrichment is presented as a percentage relative to NTERA-2 (100%).
doi:10.1371/journal.pone.0007809.g003
Epigenetics of Stem Cells
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Figure 4. Methylation and expression of genes hypomethylated in ASC in comparison with NTERA-2 cells. A, Differences of expression
between ASC and NTERA-2 (blue bars) and promoter methylation in ASC (black diamonds) and NTERA-2 (red squares) are presented for each gene.
The differences of expression, according to Affymetrix data, are shown as fold change (FC) in log2. The methylation data are average BeadArray
values. B, Bisulfite sequencing of promoter regions of COL1A2, HOXA9 and SERPINE1 in NTERA-2 and ASC cells. Promoter schematic description (black)
and the location of the CpGs (blue) examined are presented for each gene. The CpG dinucleotides (clear box: unmethylated, filled box: methylated) of
five clones and the BeadArray methylation values6standard deviation are shown for each sample. C, Expression of COL1A2, HOXA9 and SERPINE1
from Affymetrix arrays (colored rhombuses) and quantitative Q-RT-PCR (colored bars).
doi:10.1371/journal.pone.0007809.g004
Epigenetics of Stem Cells
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2006]) in 21 cell lines, including NTERA-2 (n= 3), MSC (n= 7),
MAPC (n= 4) and ADSC (n= 7). A hierarchical cluster analysis of
all the miRNAs classified the cells lines into two groups, one of
which included NTERA-2 cells and the other group including all
the different ASC (Figure S4 and Table S11). Differential
expression of 64 miRNAs was observed in ESC relative to ASC
(34 upregulated and 30 downregulated) (Table S12). However,
only a few miRNAs were differentially expressed between ASC
populations (miR-143 downregulated and miR-204 upregulated in
MAPC with respect to MSC; miR-129 and miR-199b downregu-
lated and miR-204 upregulated in MAPC respect to MSC and
miR-424 downregulated in MSC respect to ADSC) and those
differences were smaller than those observed between ESC and
ASC. A recent comparison of miRNAs differentially expressed
between ESC and differentiated cells [43] identified a unique
miRNA signature associated with ESC that, in fact, was highly
coincidental with the list of miRNAs differentially expressed in our
NTERA-2 cells compared with ASC (not shown).
The results obtained from the transcriptome and miRNA
analyses prompted us to examine whether consensus ESC genes and
differentiation genes could be regulated by differentially expressed
miRNAs. Using prediction programs we identified ZIC3, LIN28
and NANOG as putative targets for miRNAs upregulated in ASC
in comparison with NTERA-2 cells. Similarly, differentiation
genes such as DCN and COL1A2 were identified as putative targets
for miRNAs downregulated in ASC in comparison with NTERA-
2 cells. We directly examined the expression of these differentially
regulated miRNAs and their targets by Q-RT-PCR using the
different cell lines. An inverse correlation between expression of
ZIC3 and miR-137, miR-152, miR-154 and miR-155; LIN28 and let-
7c, miR-137 and miR-152 and NANOG and miR-199a and miR-199b
expression was found in ASC and NTERA-2 cells (Figure 5).
Expression of DCN and COL1A2 (upregulated in ASC compared
with NTERA-2 cells) was also inversely correlated with expression
of the miRNAs with target seed sequences for those genes miR-96,
miR-182, miR-205 (DCN) and miR-96 and miR-367 (COL1A2)
(downregulated in ASC relative to NTERA-2 cells) (Figure 5).
These results suggest a role for miRNAs in regulating ESC and
differentiation genes as a third mechanism of stem cell gene
regulation.
A recent study has described a group of six miRNAs (miR-155,
miR-708, miR-615, miR-375, miR-124a and miR-9) co-occupied
simultaneously by the ESC transcription factors OCT4, SOX2,
NANOG and TCF3 and by the Polycomb group proteins. These
miRNAs are transcriptionally silenced in ESC but are expressed in
a tissue-specific fashion in differentiated cells [18]. When we
analyzed the expression of these miRNAs we observed that
expression of miR-9 and miR124a was upregulated in NTERA-2
cells in comparison with ASC. To understand the discrepancies
with our microRNA expression data we analyzed the histone
modification and DNA methylation patterns associated with these
miRNAs. We performed a quantitative-ChIP assay using antibod-
ies against EZH2, SUZ12, H3K27m3 and H3K9m3 (marks
associated with repressed chromatin), and H3K4me3 and H3Ac
(histone modifications associated with transcriptionally active
chromatin) in three miRNAs (miR-9-1, miR-9-2 and miR-124a-1)
upregulated in NTERA-2 cells with respect to ASC. Consistent
with the expression analysis, we observed that these three miRNAs
showed an increase of H3K27m3 and H3K9m3 repressed
chromatin marks and a decrease of open chromatin marks in
ASC in comparison with NTERA-2 (Figure 6). DNA methylation
analysis did not reveal any differences between NTERA-2 cells
and ASC (Figure S5). The stronger expression of these three
miRNAs in NTERA-2 cells could be explained by the fact that
ESC transcription factors are expressed in NTERA-2 cells but not
in ASC, while the pattern of proteins of the PcG bound to ASC in
contrast to NTERA-2 cells supports a close chromatin conforma-
tion [18].
Discussion
Stem cells are characterized by their capacity to self-renew and
differentiate into committed cells. While ESC can differentiate into
any type of tissue, the potential of somatic stem cells is usually
restricted to certain types, most prominently those derived from
the same germ layer from which they are derived. Several studies
have analyzed the differences in gene expression between different
types of stem cells and identified signatures associated with stem
cell populations as well as specific subsets of genes associated with
particular types of stem cells [25,26]. Significantly less information
is available regarding the mechanism responsible for the
differences in gene expression between populations of stem cells
and although several studies have addressed the epigenetic make
up of ESC and the role of epigenetic mechanisms in their self-
renewal and differentiation [9,10,44,45], few attempts have been
made to analyze the differences in epigenetic regulation in somatic
stem cells. In this study, our comparison of the epigenetic
regulation of gene expression between well characterized popula-
tions of ASC and ESC revealed that different epigenetic signatures
characterize different populations of stem cells, whereby embry-
onic stem cell populations, with a higher differentiation potential,
exert stronger epigenetic repression of differentiation genes through
both DNA methylation and histone modifications, versus MSC
and ADSC where differentiation genes are active and exhibit active
epigenetic profiles. Interestingly, we find that MAPC, where the
differentiation potential is intermediate between ESC and these
two ASC populations, exhibit an epigenetic profile where only
repressive histone modification marks, but not DNA methylation
associate with repression of differentiation genes. In this sense, our
transcriptome results indicate that MAPC and MSC or ADSC are
populations of somatic cells whose differences in expression can be
explained by the differences in the epigenetic regulation of
differentiation genes. We therefore propose a model (Figure 7) in
which differentiation genes exhibit progressively less epigenetic
constraints. In ESC cells, differentiation genes are repressed through
both DNA methylation and repressive histone modifications. In
MAPC, differentiation genes are still repressed and PcG marks are
present but promoter DNA methylation has been lost. In MSC
and ADSC repressive histone modification marks are lost.
Other studies have also demonstrated the important role for the
PcG machinery in silencing genes that must be repressed to
maintain self renewal and pluripotency, and that become activated
during differentiation [10,40]. These studies have been carried out
in the context of muscle [46], neural [47], erythroid [48] and germ
cell [49] differentiation. However, the functional loss of PRC2
components such as EED and SUZ12 results in the upregulation
of genes associated with cell differentiation but do not affect the
self-renewal capacity of ESC, indicating that PRC2 is not essential
for pluripotency [44,50]. This is consistent with our results in
which the PRC2 repressive effect on the promoters of differentiation
genes in ASC is lost because there is a decrease in SUZ12, leading
to gene upregulation. This reduction in SUZ12 is greater in MSC
and ADSC than in MAPC, which could explain the differences in
gene expression between stem cell populations (Figure 3C). The
possible lack of direct involvement of PRC2 in regulating
pluripotency is also consistent with our observation that only 5%
of the pluripotent genes, compared with 18–20% of the
differentiation genes, have PcG marks. Thus PcG-mediated gene
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regulation in stem cells could be more relevant for genes involved
in development and differentiation than for pluripotent genes.
The differences in gene promoter DNA methylation between
ESC and ASC imply a role for methylation in the maintenance of
pluripotency since 99% of the genes differentially hypermethylated
in NTERA-2 cells relative to ASC were those known to be
involved in development and differentiation. However, methyla-
tion of gene promoters in ESC was associated with downregulation
in only 56% of the hypermethylated genes. The role of gene
promoter methylation in stem cell biology has been highlighted by
recent studies [13,51,52], which suggest that ESC differentiation is
associated with progressive demethylation of differentiation gene
Figure 5. Expression of miRNAs and their putative ESC and differentiation target genes. Expression of ESC genes -NANOG, LIN28 and
ZIC3- and differentiation genes -DCN and COL1A2- (dashed lines, log2, left vertical axis) and expression of miRNAs (colored bars, log10, right vertical
axis) predicted to regulate expression of these genes were analyzed by Q-RT-PCR in each cell line.
doi:10.1371/journal.pone.0007809.g005
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promoters and lend weight to the hypothesis that the different
potential of stem cells is also dependent on the greater
hypermethylation observed in ESC compared with somatic stem
cells. This conclusion needs to be drawn with caution since the
array used in our study contained a limited number of gene
promoters (n = 807), most of which are associated with cancer.
The overall pattern needs to be determined in genome-wide DNA
methylation studies to establish whether this analysis can be
generalized to the whole genome.
Another caveat to our conclusions arises from the fact that,
instead of using human embryonic cell lines, we used an
embryonic carcinoma cell line, which might not be considered
the best model of the pluripotent stem cell. However, recent
studies support the use of NTERA-2 as well as other embryonic
carcinoma cell lines as a model of ESC: 1) It has been published
that the expression profiles, not only of genes but also of miRNAs,
and the methylation patterns of the NTERA-2 cell line are broadly
similar to that of human ESC [37,53]; 2) Although NTERA-2 cells
are derived from an embryonic carcinoma, the methylation
pattern was identical to that of human ESC lines (as shown by the
comparison between the methylation profile of NTERA-2 in the
current study and methylation in human ESC shown in a previous
study using the same platform) [51]. These findings rule out the
possibility that the observed hypermethylation in NTERA-2 cells
were related to the origin of the cells and different from ESC
further supporting the use of NTERA-2 cells. 3) We also compared
the miRNA expression of NTERA-2 cells with the results of a
recent study in which miRNA expression was analyzed in 26 cell
lines, including human ESC, NPC, NSC, MSC and differentiated
cells. We found that miRNAs differentially expressed between
NTERA-2 cells and ASC coincided with miRNAs differentially
expressed between human ESC and ASC [43]. For all these
reasons, we believed that our results are indeed useful to
understand the biology of pluripotent stem cells such as ESC.
A final comment relates to the potential use of our results in the
understanding of the reprogramming process. The demonstration
that somatic cells can be reprogrammed to produce a fully
pluripotent state [54,55,56] has been a major breakthrough in the
field. Progress is being made towards a better understanding of the
reprogramming process. Our results are a useful contribution to
this endeavor, arguing for a stepwise model of the different
epigenetic stages, from somatic cells to progenitor and multipotent
stem cells and to pluripotent stem cells. This equips us with a
roadmap for producing specific types of stem cells depending on
clinical need.
Materials and Methods
Cell Populations
Human mesenchymal stromal cells (MSC) were established
from bone marrow from patients of 20–60 years of age. Human
adipose-derived stem cells (ADSC) were obtained from human
liposuction procedures. Multipotent adult progenitor cells (MAPC)
were established as described [30]. MAPC and MSC isolates were
obtained from the same patients. MAPC, ADSC and MAPC were
referred as adult stem cells (ASC). All samples were obtained after
Figure 6. Quantitative-ChIP assay performed on miR-9-1, miR9-3 and -miR124a1. Antibodies specific to SUZ12, EZH2, H3K27me3, H3K9me3,
H3K4me3 and H3 acetylated were used for ChIP, and then the miR-9-1, miR-9-3 and miR-124a1 levels were determined using Q-RT-PCR. Enrichment is
measured as percentage relative to NTERA-2 cells (100%).
doi:10.1371/journal.pone.0007809.g006
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the donor had given their written informed consent, in accordance
with the guidelines of the Committee on the Use of Human
Subjects in Research of the Clinica Universidad de Navarra. The
study was approved by the Ethics Committee for Research with
Human subjects at the University of Navarra. The human
NTERA-2 cell line was purchased from DSMZ-German Collec-
tion of Microorganisms and Cell Cultures (Braunschweig,
Germany).
Expression Microarrays
MAPC (n= 10), MSC (n= 8), ADSC (n= 5) and NTERA-2 cells
(n = 3; 3 different cultures) were used for the microarray analysis.
RNA isolation, labeling and hybridization to the HG-U133 Plus
2.0 GeneChip Oligonucleotide Microarray (Affymetrix Inc., Santa
Clara, CA) were performed as previously described [57]. Principal
components analysis (PCA) was used to reveal trends in the data
and to identify predominant gene expression patterns. Statistical
significance of differential expression was determined using the
Significant Analysis of Microarrays (SAM) algorithm. The log-
transformed and mean-centered intensity values of significant
differentially expressed genes were used for PCA, which was
carried out using Spotfire (Spotfire Inc., Cambridge, MA).
Quantitative RT-PCR Analysis
RNA samples used for the Q-RT-PCR were the same as those
used for hybridizing Affymetrix HG-U133 Plus 2.0 array. Primers
and probes used for real-time PCR are shown in Table S1. Gene
expression was calculated using the relative standard curve
method. GAPDH was used as a housekeeping control.
Chromatin Immunoprecipitation Assay
A sample of each population studied in Affymetrix arrays was
subjected to chromatin immunoprecipitation. ChIP assays were
performed as previously described [58,59] and the ChIP fractions
were used for quantitative-PCR assay. Immunoprecipitated
fractions were obtained with the ChIP grade antibodies anti-
Figure 7. Model of epigenetic regulation of ESC and differentiation genes in different populations of human stem cells. Genes
implicated in pluripotency (Oct4, Sox2, Nanog) are transcriptionally active in ESC due to the lack of repressive marks as well as by their own potential
to transactivate their own transcription favoring the greater differentiation potential of ESC. Differentiation genes, on the contrary are silenced on ESC
due to several epigenetic mechanisms that include expression of miRNA, DNA promoter methylation and repressive histone marks that all together
cooperate to induce down-regulation of differentiation genes. A decrease in the differentiation potential of ASC (MAPC, MSC and ADSC) is mediated
by the silencing of pluripotency genes downregulated through the expression of certain miRNA. The presence of PcG proteins (particularly SUZ12) on
the promoters of differentiation genes but the lack of methylation on MAPC could explain their reduced expression. Finally, the lack of PcG marks
along with the increase in open chromatin marks in the promoters of differentiation genes would explain the greater expression of these genes as
well as the more restricted differentiation potential of ASC (MSC and ADSC).
doi:10.1371/journal.pone.0007809.g007
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SUZ12 (ab12073), anti-EZH2 (ab3748), anti-trimethylated Lys 27
of histone 3 (H3K27me3: ab6002), anti-trimethylated Lys 4 of
histone 3 (H3K4me3: ab8580) (all from Abcam, Cambridge, MA)
and anti-acetylated histone H3 (H3Ac: 06-599, Upstate Biotech-
nologies, Lake Placid, NY).
DNA Methylation Profiling Using Universal BeadArrays
DNA samples from NTERA-2 (n= 2), MAPC (n= 4), MSC
(n= 4) and ADSC (n= 4) cells were analyzed. We used Gold-
enGateH Methylation Cancer Panel I (Illumina Inc.) for the DNA
methylation analysis. Methylation assay was performed as
described previously [41,53]. To validate the DNA methylation
data generated by the BeadArray technology, bisulfite sequencing
(BS) was performed as previously described [60,61].
MicroRNA Expression Analysis by Quantitative Real-Time
PCR (Q-RT-PCR)
Expression of 250 miRNAs was analyzed using specific primers
and TaqMan probe for each miRNA according to the TaqMan
MicroRNA Assay protocol, as previously described [62]. Relative
quantification of expression of microRNAs was calculated with the
22DDCt method (Applied Biosystems. User Bulletin Nu2 (P/N
4303859)). The data are shown as log10 of the relative quantity
(RQ) of target miRNAs, normalized and compared with
expression in NTERA-2. In order to identify microRNAs with
statistically significant changes in expression between the groups,
we performed a supervised analysis using the SAM algorithm.
Supplemental Material and Methods provides a more
detailed description of the methods used in the current studies
(Text S1).
Supporting Information
Text S1 Supplemental Material and Methods
Found at: doi:10.1371/journal.pone.0007809.s001 (0.11 MB
DOC)
Figure S1 Exploratory data analysis with PCA method on the
gene expression data of MSC, ADSC, MAPC and NTERA-2 A.
Samples plotted in the first three principal components (PC); B.
Variation captured in each PC
Found at: doi:10.1371/journal.pone.0007809.s002 (1.13 MB TIF)
Figure S2 Functional analysis of differentially expressed probe-
sets between stem cell populations Comparison between the gene
expression profile of NTERA-2 versus Adult Stem Cells (A) and
MAPC versus MSC-ADSC cells (B). The graphs show categories
overrepresented in each group according to their p-value (line, in
log10) and the number of genes in each category (bars, in log10).
Only categories with a p-value less than 0.01 were selected
Found at: doi:10.1371/journal.pone.0007809.s003 (0.54 MB TIF)
Figure S3 DNA methylation in stem cells Number of genes
differentially methylated in each comparison from supervised
analysis. The number of genes hypomethylated and hypermethy-
lated for each comparison is shown.
Found at: doi:10.1371/journal.pone.0007809.s004 (0.15 MB TIF)
Figure S4 Dendrogram of hierarchical cluster analysis based on
250 miRNA expression data. ESC, human embryonal carcinoma;
ASC, human adult stem cells; MAPC, Multipotent Adult
Progenitor Cells; MSC, Mesenchymal Stem Cells; ADSC,
Adipose-Derived Stem Cells.
Found at: doi:10.1371/journal.pone.0007809.s005 (0.20 MB TIF)
Figure S5 Promoter hypermethylation of miR-9-1, miR-9-3 and
-miR-124a1 MSP analysis of the miR-124a-1, miR-9-1 and miR-
9-3 CpG island regions in NTERA-2 and ASC. MAPC,
Multipotent Adult Progenitor Cells; MSC, Mesenchymal Stem
Cells; ADSC, Adipose-Derived Stem Cells. M: methylated allele;
U: un-methylated allele.
Found at: doi:10.1371/journal.pone.0007809.s006 (0.63 MB TIF)
Table S1 Primers and probes used for PCR. X: cycles of PCR;
aT: annealing Temperature.
Found at: doi:10.1371/journal.pone.0007809.s007 (0.06 MB
DOC)
Table S2 RMA raw data (Affymetrix’s data)
Found at: doi:10.1371/journal.pone.0007809.s008 (6.47 MB
PDF)
Table S3 Differential expression analysis between Adult Stem
Cells (ASC) and NTERA-2 using LIMMA. Differentially ex-
pressed genes with B value.3 and Fold Change (FC).2 (positive
for ASC, and negative for NTERA-2, in log2) are shown. Genes
marked in red were validated by Q-RT-PCR.
Found at: doi:10.1371/journal.pone.0007809.s009 (0.76 MB
XLS)
Table S4 Differential expression analysis between MSC-ADSC
and MAPC using LIMMA. Differentially expressed genes with B
value.3 and Fold Change (FC).2 (positive for MSC and ADSC,
and negative for MAPC, in log2) are shown. Genes marked in red
were validated by Q-RT-PCR.
Found at: doi:10.1371/journal.pone.0007809.s010 (0.59 MB
XLS)
Table S5 Consensus ESC genes up-regulated in NTERA-2 in
comparison with ASC. Table includes those genes with a FC.2
(in log2) and the PcG marks for ech gene, according to Lee’s study.
Genes marked in red were validated by Q-RT-PCR.
Found at: doi:10.1371/journal.pone.0007809.s011 (0.11 MB
XLS)
Table S6 A,Consensus differentiation genes up-regulated in
ASC compared to NTERA-2. Table includes those genes with a
FC.2 (log2) and the PcG marks for ech gene, according to Lee’s
study. Genes marked in red were validated by Q-RT-PCR. B,
Consensus differentiation genes up-regulated in MSC-ADSC in
comparison with MAPC. Table includes those genes with a FC.2
(log2) and the PcG marks for ech gene, according to Lee’s study.
Genes marked in red were validated by Q-RT-PCR.
Found at: doi:10.1371/journal.pone.0007809.s012 (0.10 MB
XLS)
Table S7 Bead-Array’s raw data
Found at: doi:10.1371/journal.pone.0007809.s013 (0.64 MB
XLS)
Table S8 A, Consensus ESC gene promoters in BeadArray
(Illumina). B, Consensus differentiation gene promoters in
BeadArray (Illumina)
Found at: doi:10.1371/journal.pone.0007809.s014 (0.18 MB
XLS)
Table S9 Differentially methylated (DM) probe-sets between
populations of stem cells. The type of promoter according to its
CpG’s content (LCP: low CpG content; ICP: intermediate CpG
content and HCP: high CpG content), the annotation assigned by
Assou et al. (ESC gene=ESC or Differentiation gene=Dif),
BeadArray’s data and PcG marks according to Lee et al, are
indicated for each probe-set. Blue represents hypomethylated
genes and yellow hypermethylated genes. A, DM Genes between
NTERA-2 and ASC. B, Genes DM between NTERA-2 and
MAPC. C, Genes DM between NTERA-2 and MSC. D, Genes
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DM between NTERA-2 and ADSC. E, Genes DM between
MAPC and MSC. F, Genes DM between MAPC and ADSC. G,
Genes DM between MSC and ADSC
Found at: doi:10.1371/journal.pone.0007809.s015 (0.09 MB
PDF)
Table S10 Differentially Methylated and Expressed Genes
between NTERA-2 and ASC
Found at: doi:10.1371/journal.pone.0007809.s016 (0.09 MB
XLS)
Table S11 DcT (cT miRNA-cT RNU6B) of 250 miRNAs
analyzed in ESC and ASC
Found at: doi:10.1371/journal.pone.0007809.s017 (0.12 MB
XLS)
Table S12 Differentially expressed miRNAs between NTERA-2
and ASC. Logarithmic values (log10) of those microRNAs which
expression is significantly reduced/increased in ASC vs NTERA-2
cell line. These values were obtained comparing the expression
value of each sample by the average value of NTERA_2 samples.
A, miRNAs up-regulated in NTERA-2 and down-regulated in
ASC. B, miRNAs up-regulated in ASC and down-regulated in
NTERA-2.
Found at: doi:10.1371/journal.pone.0007809.s018 (0.01 MB
PDF)
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